3.0(top 20%)
impact factor
683(top 20%)
papers
11.4K(top 20%)
citations
46(top 20%)
h-index
3.2(top 20%)
impact factor
753
all documents
12.1K
doc citations
65(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Angiogenesis and invasion in gliomaBrain Tumor Pathology2011226
2The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological gradesBrain Tumor Pathology2003181
3Genetic profile of astrocytic and oligodendroglial gliomasBrain Tumor Pathology2011146
4Genetic landscape of meningiomaBrain Tumor Pathology2016118
5Molecular pathogenesis of IDH mutations in gliomasBrain Tumor Pathology2012115
6Immunohistochemical analysis of the mutant epidermal growth factor, ΔEGFR, in glioblastomaBrain Tumor Pathology2004112
7Pathological review of late cerebral radionecrosisBrain Tumor Pathology2008110
8Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimagingBrain Tumor Pathology2010102
9Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological studyBrain Tumor Pathology200796
10Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencingBrain Tumor Pathology201196
11Frequent IDH1/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordomaBrain Tumor Pathology201283
12Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of responseBrain Tumor Pathology201782
13Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein BadBrain Tumor Pathology200181
14Recurrence and regrowth of benign meningiomasBrain Tumor Pathology200980
15The 2017 WHO classification of pituitary adenoma: overview and commentsBrain Tumor Pathology201877
16Expression and quantitative analysis of matrix metalloproteinase-2 and-9 in human gliomasBrain Tumor Pathology200476
17Blood–brain barrier and blood–cerebrospinal fluid barrier in normal and pathological conditionsBrain Tumor Pathology201676
18New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factorsBrain Tumor Pathology201871
19Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastasesBrain Tumor Pathology200670
20Malignant transformation of meningeal melanocytoma: A case reportBrain Tumor Pathology200369
21Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institutionBrain Tumor Pathology201769
22Correlation of diagnostic yield of stereotactic brain biopsy with number of biopsy bits and site of the lesionBrain Tumor Pathology200668
23Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutationBrain Tumor Pathology201468
24Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cellsBrain Tumor Pathology200266
25Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomasBrain Tumor Pathology201565
26Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomasBrain Tumor Pathology201565
27Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomasBrain Tumor Pathology201562
28Aberrant methylation of genes in low-grade astrocytomasBrain Tumor Pathology200059
29A miR-21 inhibitor enhances apoptosis and reduces G2-M accumulation induced by ionizing radiation in human glioblastoma U251 cellsBrain Tumor Pathology201158
30Clinicopathological study of pineal parenchymal tumors: correlation between histopathological features, proliferative potential, and prognosisBrain Tumor Pathology199957
31Matrix metalloproteinase-2 and-9 expression in astrocytic tumorsBrain Tumor Pathology200355
32High expression of L-type amino acid transporter 1 in infiltrating glioma cellsBrain Tumor Pathology200555
33Glioma-initiating cells and molecular pathology: implications for therapyBrain Tumor Pathology201155
34Expression of fascin, an actin-bundling protein, in astrocytomas of varying gradesBrain Tumor Pathology200354
35Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomasBrain Tumor Pathology201254
36Glioneuronal tumors of the central nervous systemBrain Tumor Pathology200252
37CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic targetBrain Tumor Pathology201152
38Presurgical mapping with magnetic source imaging: comparisons with intraoperative findingsBrain Tumor Pathology200051
39Pathological and clinical features of cystic and noncystic glioblastomasBrain Tumor Pathology200651
40Primary diffuse leptomeningeal glioneuronal tumorsBrain Tumor Pathology201551
41Genetic analysis of human glioblastomas using a genomic microarray systemBrain Tumor Pathology200450
42Lymphocytic infundibulo-neurohypophysitis and infundibulo-panhypophysitis regarded as lymphocytic hypophysitis variantBrain Tumor Pathology200850
43Precise comparison of protoporphyrin IX fluorescence spectra with pathological results for brain tumor tissue identificationBrain Tumor Pathology201150
44Expression of the multidrug-resistance P-glycoprotein (Pgp, MDR-1) by endothelial cells of the neovasculature in central nervous system tumorsBrain Tumor Pathology199949
45Immunohistochemical analysis of adhesion molecules and matrix metalloproteinases in malignant CNS lymphomas: a study comparing primary CNS malignant and CNS intravascular lymphomasBrain Tumor Pathology200849
46Nestin expression in astrocytic tumors delineates tumor infiltrationBrain Tumor Pathology201048
47Characteristics of glioma stem cellsBrain Tumor Pathology201348
48Calcification on CT is a simple and valuable preoperative indicator of 1p/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomasBrain Tumor Pathology201648
49MicroRNA and extracellular vesicles in glioblastoma: small but powerfulBrain Tumor Pathology201647
50Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomasBrain Tumor Pathology201647